Fertility preservation for transgender females after gender affirming treatment is effective

Adeleye, Amanda; Reid, Garrett Michael; Mok-Lin, Evelyn; Smith, James F.

doi:10.1016/j.fertnstert.2017.08.008

Cited by 5 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…11 In a retrospective study of patients discontinuing gender-affirming therapy to pursue fertility preservation, all individuals had normal semen analysis parameters an average of 4.7 months after discontinuation of gender-affirming therapy. 12 To date, no prospective studies have been published describing the time course of resumption of spermatogenesis after discontinuation of GnRH agonist or gender-affirming therapy in patients who are azoospermic while on treatment.…”

Section: Semen Cryopreservation Is a Feasible Methods Of Fertility Prementioning

confidence: 99%

Fertility Preservation Outcomes in Adolescent and Young Adult Feminizing Transgender Patients

et al. 2019

View full text Add to dashboard Cite

BACKGROUND: Fertility preservation enables patients undergoing gonadotoxic therapies to retain the potential for biological children and now has broader implications in the care of transgender individuals. Multiple medical societies recommend counseling on fertility preservation before initiating therapy for gender dysphoria; however, outcome data pre-and posttreatment are limited in feminizing transgender adolescents and young adults. METHODS: The University of Pittsburgh Institutional Research Board approved this study. Data were collected retrospectively on transgender patients seeking fertility preservation between 2015 and 2018, including age at initial consultation and semen analysis parameters.

show abstract

Section: Semen Cryopreservation Is a Feasible Methods Of Fertility Prementioning

confidence: 99%

Fertility Preservation Outcomes in Adolescent and Young Adult Feminizing Transgender Patients

et al. 2019

View full text Add to dashboard Cite

show abstract

Gender‐affirming surgeries for transgender and gender diverse individuals and associated health outcomes

Rezaei,

Miller,

Miranda

et al. 2024

Behavioral Sci & The Law

View full text Add to dashboard Cite

Gender‐affirming care is treatment that recognizes and affirms the gender identity of transgender and gender‐diverse (TGD) individuals. Though not all TGD people choose to surgically transition, gender‐affirming surgeries (GAS) are an important part of many TGD people's transition. GAS can include a wide array of procedures aimed at aligning an individual's physical characteristics and gender identity. This review describes the most common procedures considered to be GAS, detailing important relevant considerations for each procedure. These include transfeminine procedures (i.e., breast augmentation, penile inversion vaginoplasty, orchiectomy, tracheal shave, and facial feminization); transmasculine procedures (i.e., chest masculinization, hysterectomy, phalloplasty, and metoidioplasty); and other procedures (i.e., fertility preservation and hair removal). Patient outcomes and the legal landscape for GAS are also discussed to contextualize these procedures within largest discourses surrounding gender‐affirming care.

show abstract

Surgical Anatomy: Orchiectomy and Fertility Preservation Options

Owyong

Ramasamy

2021

Urological Care for the Transgender Patient

View full text Add to dashboard Cite

Fertility preservation for transgender females after gender affirming treatment is effective

Cited by 5 publications

References 0 publications

Fertility Preservation Outcomes in Adolescent and Young Adult Feminizing Transgender Patients

Fertility Preservation Outcomes in Adolescent and Young Adult Feminizing Transgender Patients

Gender‐affirming surgeries for transgender and gender diverse individuals and associated health outcomes

Surgical Anatomy: Orchiectomy and Fertility Preservation Options

Contact Info

Product

Resources

About